Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Debt to Equity Ratio of 0.01 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-3.20M |
|
-- |
|
-- |
|
$3.27M |
|
$-3.27M |
|
$0.08M |
|
$-3.19M |
|
$-3.19M |
|
$-3.20M |
|
$-3.20M |
|
$-3.20M |
|
$-3.20M |
|
$-3.27M |
|
$-3.27M |
|
7.02M |
|
7.02M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$23.56M |
|
-- |
|
-- |
|
$23.56M |
|
$6.12M |
|
-- |
|
-- |
|
$6.12M |
|
$17.44M |
|
$17.44M |
|
$17.44M |
|
12.81M |
|
| Cash Flow Statement Financials | |
$-3.80M |
|
-- |
|
$11.55M |
|
$14.44M |
|
$22.19M |
|
$7.75M |
|
$0.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.85 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.01 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.80M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.33% |
|
-18.33% |
|
-13.57% |
|
-18.33% |
|
$1.36 |
|
$-0.54 |
|
$-0.54 |
|